Related Experiment Video
Updated: Mar 20, 2026
09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
4.4K
MicroRNA expression in the vildagliptin-treated two- and three-dimensional HepG2 cells
Yasunari Yamashita1, Mitsutoshi Asakura2, Ryo Mitsugi1
1Department of Pharmaceutics, School of Pharmacy, Kitasato University, Minato-ku, Tokyo, Japan.
Drug Metabolism and Pharmacokinetics
|May 23, 2016
Summary
Vildagliptin, a type 2 diabetes drug, significantly altered specific microRNAs (miRNAs) in mouse livers. However, these changes were not replicated in standard cell cultures, highlighting the need for advanced models to study drug-induced liver injury.
Area of Science:
- Pharmacology
- Hepatology
- Molecular Biology
Background:
- Vildagliptin, a dipeptyl peptidase-4 inhibitor, treats type 2 diabetes but can cause liver dysfunction.
- The molecular mechanisms underlying vildagliptin-induced hepatotoxicity are not fully understood.
- MicroRNAs (miRNAs) are increasingly implicated in drug-induced liver injury.
Purpose of the Study:
- To identify hepatic miRNAs regulated by vildagliptin treatment in vivo.
- To compare miRNA expression changes in different in vitro models (2D vs. 3D cell cultures) versus in vivo findings.
Main Methods:
- Vildagliptin was administered to mice to assess liver miRNA expression.
- HepG2 cells were cultured in 2D and 3D models and treated with vildagliptin.
- Quantitative real-time PCR was used to measure miRNA levels (miR-222 and miR-877).
Main Results:
- Vildagliptin significantly induced miR-222 (31-fold) and miR-877 (53-fold) in mouse livers.
- No significant miRNA regulation was observed in vildagliptin-treated 2D HepG2 cells.
- 3D HepG2 cell cultures showed reduced miR-222 expression and only slight induction by vildagliptin; miR-877 was not induced.
Conclusions:
- Vildagliptin induces specific toxicity-associated miRNAs in vivo, but this response is not recapitulated in standard 2D cell cultures.
- Three-dimensional cell culture models offer a more relevant in vitro system for studying vildagliptin's effects on miRNA expression.
- Discrepancies between in vivo and in vitro miRNA responses highlight the need for further investigation and improved models for drug-induced hepatotoxicity research.
